Hepatitis B virus: inactive carriers.
Sharma SK, Saini N, Chwla Y.
Virol J. 2005 Sep 28;2:82. doi: 10.1186/1743-422X-2-82.
Reactivation of hepatitis-B virus.
[No authors listed]
Lancet. 1977 Mar 12;1(8011):578-80.
Chinese herbal medicine for carriers of the hepatitis B virus: an updated systematic review and meta-analysis.
Yang Y, Jiang HY, Shi Y, He JL, Su S, Chen Z.
Pharmazie. 2014 Oct;69(10):723-30.
Introduction to 'Hepatitis B virus heterogeneity--a means to personalized care'.
Bonino F; 'Hepatitis B virus heterogeneity--a means to personalized care' steering committee.
Antivir Ther. 2010;15 Suppl 3:1-2. doi: 10.3851/IMP1618.
Hepatitis B vaccine.
[No authors listed]
Lancet. 1980 Dec 6;2(8206):1229-30.
Hepatitis B virus infection in non-human primates.
Sa-Nguanmoo P, Rianthavorn P, Amornsawadwattana S, Poovorawan Y.
Acta Virol. 2009;53(2):73-82. doi: 10.4149/av_2009_02_73.
Does isoniazid cause more serious hepatotoxicity in hepatitis B virus carriers?
Nguyen MH, Garcia G.
Am J Gastroenterol. 2002 May;97(5):1092-3. doi: 10.1111/j.1572-0241.2002.05700.x.
Asymptomatic hepatitis B carriers who were vaccinated at birth.
Wang X, Chen Q, Li H, Wang C, Hu L, Yang Q, Ren C, Liu H, Zheng Z, Harrison TJ, Fang ZL.
J Med Virol. 2019 Aug;91(8):1489-1498. doi: 10.1002/jmv.25461. Epub 2019 Mar 28.
Novel hepatitis B virus subgenotype A8 and quasi-subgenotype D12 in African-Belgian chronic carriers.
Thijssen M, Trovão NS, Mina T, Maes P, Pourkarim MR.
Int J Infect Dis. 2020 Apr;93:98-101. doi: 10.1016/j.ijid.2020.01.048. Epub 2020 Jan 28.
Are hepatitis B carriers more vulnerable to exercise-related liver injury? Recent evidence from a 7-day ultramarathon.
Huang YS.
J Chin Med Assoc. 2016 Apr;79(4):169-70. doi: 10.1016/j.jcma.2015.12.003. Epub 2016 Feb 22.
